C07F 9/650994
Condensed with carbocyclic rings or carbocyclic ring systems
Official title: {condensed with carbocyclic rings or carbocyclic ring systems}
C07F9/650994 (Condensed with carbocyclic rings or carbocyclic ring systems) appears on 61 US grants and 30 published applications in this corpus.
Search patents in C07F- Granted patents
- 61
- Published applications
- 30
- Assignees
- 43
- Inventors
- 195
- Latest grant
- 3 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 2 | 0 |
| 1980 | 3 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 4 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 2 | 1 |
| 2009 | 2 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 4 |
| 2018 | 2 | 3 |
| 2019 | 4 | 2 |
| 2020 | 1 | 3 |
| 2021 | 4 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 3 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Method for producing optically active 2, 3-bisphosphinopyrazine derivative and method for producing optically active phosphine transition metal complex3 Oct 2023US 11,773,120 B2Nippon Chemical Industrial Co., Ltd.
- Phosphine transition metal complex, method for producing same, and anticancer agent23 Nov 2021US 11,180,516 B2Nippon Chemical Industrial Co., Ltd.
- 2,3-bisphosphinopyrazine derivative, method for producing same, transition metal complex, asymmetric catalyst, and method for producing organic boron compound10 Aug 2021US 11,084,835 B2National University Corporation Hokkaido University
- Optically active substituted 2,3-bisphosphinoquinoxalines and processes for producing the same6 Jul 2021US 11,053,265 B2National University Corporation Hokkaido University
- Process for preparing optically active 2,3-bisphosphino-substituted quinoxalines1 Jun 2021US 11,021,500 B2Nippon Chemical Industrial Co., Ltd.
- Novel organic monomolecular compound with modified electron transport characteristics, and device including same19 Jun 2025US 2025/0204250 A1Pukyong National University Industry-University Cooperation Foundation
- Multi-coordinate gold-phosphine compounds and method of use9 Nov 2023US 2023/0357292 A1
- Hypoxia-activated dna alkylating agent and medical use thereof26 Oct 2023US 2023/0339991 A1Ascentawits Pharmaceuticals, Ltd.
- Anticancer compound and medical use thereof26 Jan 2023US 2023/0026163 A1Ascentawits Pharmaceuticals, Ltd.
- Salt of egfr inhibitor, crystal form, and preparation method therefor21 Apr 2022US 2022/0119431 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- Electrochromic device368US 6,870,657 B1University College Dublin · 2005
- Heterocyclic compounds and their preparation and use97US 5,646,146 ANovo Nordisk A/S · 1997
- Phosphonic acid derivatives65US 5,719,303 AEisai Co., Ltd. · 1998
- [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives47US 5,168,103 AAmerican Home Products Corporation · 1992
- Pro drugs for selective drug delivery32US 5,773,592 A1998